Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Equities research analysts at Zacks Research dropped their Q3 2026 earnings per share estimates for Acadia Healthcare in a research note issued on Wednesday, July 16th. Zacks Research analyst R. Sipani now forecasts that the company will post earnings of $0.92 per share for the quarter, down from their prior forecast of $0.93. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share.
A number of other research firms have also recently weighed in on ACHC. Barclays decreased their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a "hold" rating in a research note on Monday, June 2nd. KeyCorp decreased their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Guggenheim started coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. Finally, Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $47.94.
Check Out Our Latest Analysis on Acadia Healthcare
Acadia Healthcare Price Performance
ACHC opened at $21.92 on Monday. Acadia Healthcare has a twelve month low of $20.36 and a twelve month high of $82.41. The firm has a market cap of $2.02 billion, a price-to-earnings ratio of 10.80, a PEG ratio of 4.18 and a beta of 0.93. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The company has a fifty day simple moving average of $23.07 and a 200 day simple moving average of $30.06.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. The business had revenue of $770.51 million for the quarter, compared to the consensus estimate of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The company's revenue was up .3% on a year-over-year basis. During the same period last year, the business posted $0.84 EPS.
Hedge Funds Weigh In On Acadia Healthcare
Hedge funds and other institutional investors have recently bought and sold shares of the stock. UMB Bank n.a. lifted its holdings in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock valued at $38,000 after buying an additional 1,234 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after acquiring an additional 1,004 shares during the period. Quadrant Capital Group LLC boosted its holdings in shares of Acadia Healthcare by 287.1% during the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company's stock valued at $50,000 after acquiring an additional 933 shares during the period. Finally, State of Wyoming bought a new position in shares of Acadia Healthcare during the fourth quarter worth about $56,000.
Acadia Healthcare Company Profile
(
Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.